Dexcom G7 recall overview:
- Who: Dexcom Inc. is notifying users who may have received or purchased Dexcom G7 Continuous Glucose Monitoring sensors from two specific affected lots.
- Why: Sensors designated as scrap were stolen before they could be destroyed, then resold by an unauthorized third party into the market.
- Where: The Dexcom G7 recall affects consumers in the United States.
Dexcom is alerting users after discovering that two lots of Dexcom G7 sensors — originally set aside as scrap and intended for destruction — were stolen and resold through unauthorized channels.
The company announced the safety alert on May 26, noting it was uncovered through internal quality and accounting reviews.
Scrapping sensors that fail to meet Dexcom’s quality standards is a standard part of the company’s manufacturing process. Affected units are normally sent to a third-party vendor for destruction and recycling. In this case, however, product from two lots was diverted before that process was completed.
The two affected lot numbers are 1725204004 and 1725069002. Dexcom traced the unauthorized sales back to Pharmsource LLC, a company that is not an authorized Dexcom distributor but supplies some independent pharmacies and DME distributors across the United States.
Pharmacies that sourced products through Pharmsource are encouraged to carefully review their inventory.
Customers who receive Dexcom G7 sensors through the company’s authorized distributor network — which includes major pharmacy retailers and medical distributors — are not affected. Educational samples are also unaffected.
Dexcom safety alert: Potential risks vary by lot number
The two stolen lots carry different risk profiles. Sensors from lot 1725204004 may not have been properly sterilized, raising the risk of skin infection at the sensor site.
Sensors from lot 1725069002 come from a batch that showed an elevated internal testing failure rate, meaning they carry a greater chance of providing no glucose readings at all.
According to the recall notice, no severe adverse events have been reported in connection with the stolen product as of the announcement date.
Users are urged not to use sensors from either affected lot and to contact Dexcom directly for replacements. The company is coordinating with the FDA and other authorities to investigate how the theft occurred and hold those responsible accountable.
For more information, consumers can visit the Dexcom website’s theft check tool to verify whether their sensors are from an affected lot and learn what steps to take.
Replacement sensors can be requested by calling Dexcom Customer Support at 1-844-478-1600.
Meanwhile, Dexcom is facing a class action lawsuit claiming some G7 monitors were defective while others failed to last the advertised 10-day wear period.
Are you affected by this Dexcom G7 recall? Let us know in the comments.
Don’t Miss Out!
Check out our list of Class Action Lawsuits and Class Action Settlements you may qualify to join!
Read About More Class Action Lawsuits & Class Action Settlements:
